Laura Entis

Most Recent Articles by Laura Entis

Drug list prices in DTC ads? Easier said than done

Drug list prices in DTC ads? Easier said than done

By

For one of President Trump's proposals for lowering the cost of drugs, the path to implementation could be long.

Five things for pharma marketers to know: Tuesday, May 15, 2018

Five things for pharma marketers to know: Tuesday, May 15, 2018

By

Feds join whistleblower case against Insys; Kleiner Perkins Caufield partner Seidenberg departs; Lilly strikes second acquisition deal in a week.

Five things for pharma marketers to know: Monday, May 14, 2018

Five things for pharma marketers to know: Monday, May 14, 2018

By

Beam Therapeutics raises $87 million in Series A funding; Trump drug-pricing plan largely spares big pharma; Novartis regrets Cohen consulting pact.

Cannabis gets the iPhone treatment

Cannabis gets the iPhone treatment

By

Thanks to legalization, a new breed of startups are changing the nature of cannabis advertising.

Five things for pharma marketers to know: Tuesday, May 8, 2018

Five things for pharma marketers to know: Tuesday, May 8, 2018

By

Takeda, Shire reach a deal; Walmart to restrict opioid prescriptions; Glaxo launches global media review.

More Articles by Laura Entis